Recombinant tissue plasminogen activator following paediatric cataract surgery

British Journal of Ophthalmology

Volumn 84, Issue 9, 2000, Pages 983-986

  Mehta, J S ^a   Adams, G G W ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BETAMETHASONE SODIUM PHOSPHATE; CEFUROXIME; CHLORAMPHENICOL; CYCLOPENTOLATE; POLY(METHYL METHACRYLATE);

ADJUVANT THERAPY; ARTICLE; CATARACT; CATARACT EXTRACTION; CHILD; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; EYE INFECTION; EYE INFLAMMATION; FEMALE; FOLLOW UP; GRANULATION TISSUE; HUMAN; IMMUNOTHERAPY; LENS IMPLANT; MALE; MEMBRANE FORMATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ANTERIOR CHAMBER; CATARACT EXTRACTION; CHILD; CHILD, PRESCHOOL; FEMALE; FIBRIN; FIBRINOLYTIC AGENTS; FIBROSIS; HUMANS; INFANT; MALE; POSTOPERATIVE COMPLICATIONS; SERINE ENDOPEPTIDASES; TISSUE PLASMINOGEN ACTIVATOR; VISUAL ACUITY;

EID: 0033833168     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.9.983     Document Type: Article

References (27)

1. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery
2. Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children
3. Fibrinoid syndrome: A severe complication of vitrectomy surgery in diabetes
4. The significance of inflammatory reactions following cataract extraction and intraocular lens implantation
5. The use of recombinant tissue plasminogen activator for intracameral fibrinolysis following cataract surgery
6. Treatment of post-cataract fibrinous membranes with tissue plasminogen activator
7. Retrospective comparison of techniques to prevent secondary cataract formation after posterior chamber intraocular lens implantation in infants and children
8. Surgical technique, visual outcome, and complications of pediatric intraocular lens implantation
9. Tissue plasminogen activator in human aqueous and its possible therapeutic significance
10. Postoperative fluctuation of tissue plasminogen activator (t-PA) in aqueous humor of pseudophakes
11. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells
12. Intraocular fibrinolysis with recombinant human tissue plasminogen activator; experimental treatment in a rabbit model
13. Evaluation of topically administered tissue plasminogen activator for intraocular fibrinolysis in dogs
14. Tissue plasminogen activator and the corneal endothelium
15. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit
16. Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator
17. Clinical use of recombinant plasminogen activator for intraocular fibrinolysis
18. The use of tissue plasminogen activator in post-traumatic hyphema
19. Tissue plasminogen activator-assisted surgical excision of subfoveal choroidal neovascularization in age-related macular degeneration
20. Tissue plasminogen activator treatment of postoperative intraocular fibrin
21. Band-like keratopathy after treatment of postoperative fibrin reaction with tissue plasminogen activator
22. Etiology of corneal opacities after plasminogen activator-induced fibrinolysis of the anterior chamber
23. Acute band-shaped keratopathy after intraocular fibrinolysis with recombinant tissue plasminogen activator (rt-PA)
24. Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: A prospective randomised multicentre study
25. Lack of effectiveness of tissue plasminogen activator 20 or more days after vitrectomy
26. Intraocular penetration of topical tissue plasminogen activator